Copyright
©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5524-5531
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5524
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5524
Figure 2 Observed decline in hepatitis B virus DNA levels from baseline to week 48 in hepatitis B e antigen-negative patients (A) and hepatitis B e antigen-positive patients (B).
LLoQ: Lower limit of quantification; HBV: Hepatitis B virus.
- Citation: Pan CQ, Chan S, Trinh H, Yao A, Bae H, Lou L. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B. World J Gastroenterol 2015; 21(18): 5524-5531
- URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5524.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5524